Davis Aaron I. - 22 Mar 2022 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role: Director
Signature: /s/ Aaron I. Davis
Issuer symbol: ITOS
Transactions as of: 22 Mar 2022
Net transactions value: +$1,625,489
Form type: 4
Filing time: 24 Mar 2022, 21:00:25 UTC
Previous filing: 18 Jan 2022
Next filing: 02 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITOS	Common Stock	Purchase	$678,938	+21,300	+0.68%	$31.88	3,163,358	22 Mar 2022	See footnote	F1
transaction	ITOS	Common Stock	Purchase	$122,432	+3,700	+0.12%	$33.09	3,167,058	22 Mar 2022	See footnote	F1
transaction	ITOS	Common Stock	Purchase	$167,139	+5,000	+0.16%	$33.43	3,172,058	22 Mar 2022	See footnote	F1
transaction	ITOS	Common Stock	Purchase	$656,980	+20,000	+0.63%	$32.85	3,192,058	23 Mar 2022	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.

Content

These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.